Research
Since 2000, LRAAC has conducted research for new treatments for allergies and asthma. In our 17 years we have completed over 150 clinical trials. If you would like to contact us regarding information about current clinical trials at LRAAC, call Mindy DeMarco RN,BSN,CCRP at 501-224-1156 Option 7.
Current Trials
Biocryst HAE: Oral treament for prevention of HAE attacks. Compensation up to $2800
Updated 2-5-18
GSK 107116: Children 4-17 with Uncontrolled Asthma. Compensation up to $630
Updated 2-5-18
EVA 21287: Patient perception of biologics in severe asthma. Compensation up to $100
Phone interview
Novartis CQGE031C2201E1: Adults with Chronic Urticaria
In follow up- completed enrollment 4/2017
Stallergenes : House Dust Mite Allergy Oral Immunotherapy
In follow up- completed enrollment 5/2017
CAPSTONE 2: Influenza Treatment in High Risk Flu Patients
Updated 2-5-18
GSK 205715: Adults 18+ with Inadequately Controlled Asthma, 9 Visits over 13 Months, Compensation up to $1235
Updated 6-20-17
GSK 114971: Males 5-8 and Females 5-7 with Asthma, 20 Visits over 16 months, Compensation up to $1100
Updated 6-20-17
TEVA FSS-AS-30003: Patients 4-11 with Persistent Asthma, 9 Visits over 12 Weeks, Compensation up to $450
Updated 6-20-17
Study Locations
Little Rock Allergy & Asthma CRC
18 Corporate HIll, Suite 110
Little Rock, AR 72205
Phone: +1 (501) 224-1156
Fax: +1 (501) 537-2090